Literature DB >> 9886076

Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices.

J De Alba1, A Cárdenas, M A Moro, J C Leza, P Lorenzo, L Boscá, I Lizasoain.   

Abstract

The precise role that nitric oxide (NO) plays in the mechanisms of ischemic brain damage remains to be established. The expression of the inducible isoform (iNOS) of NO synthase (NOS) has been demonstrated not only in blood and glial cells using in vivo models of brain ischemia-reperfusion but also in neurons in rat forebrain slices exposed to oxygen-glucose deprivation (OGD). We have used this experimental model to study the effect of OGD on the neuronal isoform of NOS (nNOS) and iNOS. In OGD-exposed rat forebrain slices, a decrease in the calcium-dependent NOS activity was found 180 min after the OGD period, which was parallel to the increase during this period in calcium-independent NOS activity. Both dexamethasone and cycloheximide, which completely inhibited the induction of the calcium-independent NOS activity, caused a 40-70% recovery in calcium-dependent NOS activity when compared with slices collected immediately after OGD. The NO scavenger oxyhemoglobin produced complete recovery of calcium-dependent NOS activity, suggesting that NO formed after OGD is responsible for this down-regulation. Consistently, exposure to the NO donor (Z)-1-[(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-iu m-1,2-diolate (DETA-NONOate) for 180 min caused a decrease in the calcium-dependent NOS activity present in control rat forebrain slices. Furthermore, OGD and DETA-NONOate caused a decrease in level of both nNOS mRNA and protein. In summary, our results indicate that iNOS expression down-regulates nNOS activity in rat brain slices exposed to OGD. These studies suggest important and complex interactions between NOS isoforms, the elucidation of which may provide further insights into the physiological and pathophysiological events that occur during and after cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886076     DOI: 10.1046/j.1471-4159.1999.0720248.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Cheryl Smith; Kevin Engels; Jean L Olson; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

2.  Effect of ischemia in vivo and oxygen-glucose deprivation in vitro on NOS pools in the spinal cord: comparative study.

Authors:  Mária Kolesárová; Jaroslav Pavel; Nadezda Lukácová; Dalibor Kolesár; Jozef Marsala
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

3.  Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats.

Authors:  Arturo L Colón; José L M Madrigal; Luis A Menchén; María A Moro; Ignacio Lizasoain; Pedro Lorenzo; Juan C Leza
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

4.  Neuroprotective Effects of Astaxanthin in Oxygen-Glucose Deprivation in SH-SY5Y Cells and Global Cerebral Ischemia in Rat.

Authors:  Dae-Hee Lee; Yong J Lee; Ki Han Kwon
Journal:  J Clin Biochem Nutr       Date:  2010-07-06       Impact factor: 3.114

5.  Positive feedback regulation of human inducible nitric-oxide synthase expression by Ras protein S-nitrosylation.

Authors:  Martin Lee; Jonathan C Choy
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

6.  Involvement of nitric oxide in spatial memory deficits in status epilepticus rats.

Authors:  Zhao Wei Liu; Tao Zhang; Zhuo Yang
Journal:  Neurochem Res       Date:  2007-06-05       Impact factor: 3.996

7.  Nitric oxide manipulation: a therapeutic target for peripheral arterial disease?

Authors:  Gareth Williams; Xu Shi-Wen; David Abraham; Sadasivam Selvakumar; Daryll M Baker; Janice C S Tsui
Journal:  Cardiol Res Pract       Date:  2012-03-20       Impact factor: 1.866

8.  Gastrointestinal motility changes and myenteric plexus alterations in spontaneously diabetic biobreeding rats.

Authors:  Ingrid Demedts; Tatsuhiro Masaoka; Sebastien Kindt; Gert De Hertogh; Karel Geboes; Ricard Farré; Pieter Vanden Berghe; Jan Tack
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

9.  A spontaneous animal model of intestinal dysmotility evoked by inflammatory nitrergic dysfunction.

Authors:  Tatsuhiro Masaoka; Tim Vanuytsel; Christophe Vanormelingen; Sebastien Kindt; Shadea Salim Rasoel; Werend Boesmans; Gert De Hertogh; Ricard Farré; Pieter Vanden Berghe; Jan Tack
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.